Show simple item record

dc.contributor.authorYolli, H.
dc.contributor.authorDemir, M.E.
dc.contributor.authorYildizhan, R.
dc.date.accessioned2021-12-21T08:40:42Z
dc.date.available2021-12-21T08:40:42Z
dc.date.issued2020
dc.identifier.issn3906663
dc.identifier.urihttps://doi.org/10.31083/J.CEOG.2020.04.5359
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1158
dc.description.abstractObjectives: Lipocalin-2 (LCN-2) is an immune modulator. It is highly associated with inflammation, ischemia, neoplastic invasion, and transformation. Preeclampsia (PE) is a pregnancy-related disease resulting from the incomplete invasion of trophoblasts.
dc.description.sponsorshipThe study was supported by Van Yuzuncu Yil University the scientific research program. Thanks to all the peer reviewers and editors for their opinions and suggestions.
dc.language.isoEnglish
dc.publisherIMR Press Limited
dc.rightsAll Open Access, Bronze
dc.titleNeutrophil gelatinase associated lipocalin-2 (Ngal) levels in preeclampsia
dc.typeArticle
dc.relation.journalClinical and Experimental Obstetrics and Gynecology
dc.identifier.issue4
dc.identifier.startpage519
dc.identifier.endpage523
dc.identifier.volume47
dc.identifier.doi10.31083/J.CEOG.2020.04.5359
dc.relation.issue4
dc.relation.volume47


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record